Page 8 - James Fingleton News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Thursday, 8 July 2021, 11:46 am With hospitals across the country struggling with high numbers of babies and young children seriously ill with Respiratory Syncytial Virus (RSV), and schools and kindergartens reporting record numbers of children off sick, it’s vital we all do our part to stop the spread of winter germs, says the Asthma and Respiratory Foundation NZ (ARFNZ). RSV is a common virus, and in many cases the symptoms are like cold symptoms and can be treated at home. However, it is also the most common cause of hospitalisation for lower respiratory tract infections in under-two-ye...

Press Release – Asthma and Respiratory Foundation of New Zealand With hospitals across the country struggling with high numbers of babies and young children seriously ill with Respiratory Syncytial Virus (RSV), and schools and kindergartens reporting record numbers of children off sick, it’s vital we all do our part to stop the spread of winter germs, says the Asthma and Respiratory Foundation NZ (ARFNZ). RSV is a common virus, and in many cases the symptoms are like cold symptoms and can be treated at home. However, it is also the most common cause of hospitalisation for lower respirator...

DAVID WHITE/STUFF Body Positive executive director Mark Fisher said the organisation first contacted authorities calling for those with HIV to be eligible under group 3 in March. It’s welcome news to those who have been campaigning on behalf of those most at risk. Since March, HIV support organisation Body Positive have been calling for the Government to allow those living with HIV – a virus which attacks the immune system – to be included in group 3, as they are at greater risk of severe illness from Covid-19. Its executive director, Mark Fisher,​ said it was good news he could fi...

Two in one asthma treatment gets global acclaim 04 May 2021 11:48 AM More Related Stories A New Zealand-developed approach to managing asthma is being picked up internationally. Asthma and Respiratory Foundation medical director James Fingleton says the latest guidelines from GINA, the Global Initiative for Asthma, recommend 2 in 1 reliever therapy, in which patients receive both a preventer and reliever treatment at the same time. The foundation adopted the approach last year based on three large randomised trials, and Dr Fingleton says it’s considered the biggest paradigm advance in...

Tuesday, 4 May 2021, 9:28 am GINA, the Global Initiative for Asthma, has released its strategy framework, and the Asthma and Respiratory Foundation NZ (ARFNZ) is delighted to see that the international asthma recommendations have changed to follow a similar approach to the New Zealand asthma guidelines. The international strategy now has a separate algorithm based on the preferred option of 2 in 1 reliever therapy for people living with asthma. Last year, ARFNZ was the first to recommend a separate stepwise approach like this in its guidelines. GINA have now followed the recommendation. The...